Related Experiment Video

Updated: May 8, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Cardiovascular burden associated with uremic toxins in patients with chronic kidney disease

Hamid Moradi1, Domenic A Sica, Kamyar Kalantar-Zadeh

  • 1University of California Irvine School of Medicine, Orange, Calif., USA.

American Journal of Nephrology
|August 15, 2013
PubMed

Insights

Uremic toxins contribute to cardiovascular disease in chronic kidney disease (CKD) patients, increasing risks. Emerging treatments show promise, but large trials are needed to confirm their effectiveness in managing these toxic effects.

Area of Science:

  • Nephrology
  • Cardiology
  • Toxicology

Background:

  • Uremic toxins accumulate in chronic kidney disease (CKD), adversely impacting multiple organs, particularly the cardiovascular system.
  • This accumulation leads to significant patient morbidity and mortality, making toxin alleviation a key management priority.

Purpose of the Study:

  • To review the evidence linking uremic toxins to cardiovascular morbidity and mortality in CKD patients with slowly developing uremia.
  • To summarize data on potential treatments for mitigating the adverse cardiovascular effects of uremic toxins.

Main Methods:

  • Literature review focusing on uremic toxins and cardiovascular outcomes in CKD.
  • Exclusion of cardiovascular effects related to acute kidney injury and rapid azotemia.

Main Results:

  • Uremic toxins are strongly associated with increased cardiovascular morbidity and mortality in CKD.
  • While preclinical data are extensive, clinical studies on cardiovascular outcomes are recent.

Conclusions:

  • Uremic toxins significantly contribute to cardiovascular disease progression in CKD patients.
  • Further research is essential to fully understand the impact of uremic toxins on cardiovascular health.
  • Preliminary evidence suggests beneficial treatments exist, but large randomized trials are required to validate their utility.
Abstract

More Related Videos

Assessment of Vascular Function in Patients With Chronic Kidney Disease08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...